Immunodeficiency References

ASCIA HP Immunodeficiency References 2025299.29 KB  

Abolhassani, H., Sadaghiani, M. S., Aghamohammadi, A., Ochs, H. D., & Rezaei, N. (2012). Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis. Journal of clinical immunology, 32, 1180-1192. https://doi.org/10.1007/s10875-012-9720-1  

Adrian YS Lee, P. E. G. (2014). Evaluating for immunodeficiency in children with recurrent infection. Australian Journal for General Practitioners, 43, 629-632. https://www.racgp.org.au/afp/2014/september/evaluating-for-immunodeficiency-in-children-with-r  

Agarwal, S., Ferreira, V. P., Cortes, C., Pangburn, M. K., Rice, P. A., & Ram, S. (2010). An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol, 185(1), 507-516. https://doi.org/10.4049/jimmunol.0903598  

Åhlin, A., Fugeläng, J., de Boer, M., Ringden, O., Fasth, A., & Winiarski, J. (2013). Chronic granulomatous disease-haematopoietic stem cell transplantation versus conventional treatment. Acta Paediatr, 102(11), 1087-1094. https://doi.org/10.1111/apa.12384  

Akalu, Y. T., & Bogunovic, D. (2024). Inborn errors of immunity: an expanding universe of disease and genetic architecture. Nature Reviews Genetics, 25(3), 184-195. https://doi.org/10.1038/s41576-023-00656-z  

Al-Herz, W., Bousfiha, A., Casanova, J.-L., Chatila, T., Conley, M. E., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Gaspar, H. B., Holland, S. M., Klein, C., Nonoyama, S., Ochs, H. D., Oksenhendler, E., Picard, C., Puck, J. M., Sullivan, K., & Tang, M. L. K. (2014). Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency [Classification]. Frontiers in Immunology, Volume 5 - 2014. https://doi.org/10.3389/fimmu.2014.00162  

Ameratunga, R., Ahn, Y., Steele, R., & Woon, S. T. (2019). Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthood. Clinical and Experimental Immunology, 198(2), 224-232. https://doi.org/10.1111/cei.13345  

Ameratunga, R., Woon, S.-T., Brewerton, M., Koopmans, W., Jordan, A., Brothers, S., & Singh, R. (2011). Primary immune deficiency disorders in the South Pacific: the clinical utility of a customized genetic testing program in New Zealand. Annals of the New York Academy of Sciences, 1238(1), 53-64. https://doi.org/10.1111/j.1749-6632.2011.06238.x   

Ameratunga, R., Woon, S.-T., Gillis, D., Koopmans, W., & Steele, R. (2013). New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clinical and Experimental Immunology, 174(2), 203-211. https://doi.org/10.1111/cei.12178  

Anderson, J. T., Cowan, J., Condino-Neto, A., Levy, D., & Prusty, S. (2022). Health-related quality of life in primary immunodeficiencies: Impact of delayed diagnosis and treatment burden. Clinical Immunology, 236, 108931. https://doi.org/10.1016/j.clim.2022.108931  

APIIEG. (2009). Recommendations for the use of Immunoglobulin Replacement Therapy in Immune Deficiency.  . http://www.korektorzdrowia.pl/wp-content/uploads/apiieg_2009.pdf  

Aranda, C. S., Gouveia-Pereira, M. P., da Silva, C. J. M., Rizzo, M. C. F. V., Ishizuka, E., de Oliveira, E. B., & Condino-Neto, A. (2024). Severe combined immunodeficiency diagnosis and genetic defects. Immunological Reviews, 322(1), 138-147. https://doi.org/10.1111/imr.13310   

Arkwright, P. D., & Gennery, A. R. (2011). Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Annals of the New York Academy of Sciences, 1238(1), 7-14. https://doi.org/10.1111/j.1749-6632.2011.06206.x  

ASCIA-TAPID. (2019). Consensus Guideline: Diagnosis, management and transplantation of severe combined immunodeficiency in Australia and New Zealand. . https://www.allergy.org.au/hp/papers/ascia-guidelines-scid-tapid

Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook, Australian Government Department of Health and Aged Care, Canberra, 2022, https://immunisationhandbook.health.gov.au  

Ballow, M., Sánchez-Ramón, S., & Walter, J. E. (2022). Secondary Immune Deficiency and Primary Immune Deficiency Crossovers: Hematological Malignancies and Autoimmune Diseases. Front Immunol, 13, 928062. https://doi.org/10.3389/fimmu.2022.928062   

Berger, M. (2011). Incidence of Infection is Inversely Related to Steady-State (Trough) Serum IgG Level in Studies of Subcutaneous IgG in PIDD. Journal of clinical immunology, 31(5), 924-926. https://doi.org/10.1007/s10875-011-9546-2  

Bezrodnik, L., Gómez Raccio, A., Belardinelli, G., Regairaz, L., Díaz Ballve, D., Seminario, G., Moreira, I., Riganti, C., Cantisano, C., Díaz, H., & Di Giovanni, D. (2013). Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina. Journal of clinical immunology, 33(7), 1216-1222. https://doi.org/10.1007/s10875-013-9916-z   

Bonilla, F. A., Barlan, I., Chapel, H., Costa-Carvalho, B. T., Cunningham-Rundles, C., de la Morena, M. T., Espinosa-Rosales, F. J., Hammarström, L., Nonoyama, S., Quinti, I., Routes, J. M., Tang, M. L. K., & Warnatz, K. (2016). International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. The Journal of Allergy and Clinical Immunology: In Practice, 4(1), 38-59. https://doi.org/10.1016/j.jaip.2015.07.025  

Bonilla, F. A., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Hsu, J. T., Keller, M., Kobrynski, L. J., Komarow, H. D., Mazer, B., Nelson, R. P., Jr., Orange, J. S., Routes, J. M., Shearer, W. T., Sorensen, R. U., Verbsky, J. W., Bernstein, D. I., Blessing-Moore, J., Lang, D.,…Verbsky, J. W. (2015). Practice parameter for the diagnosis and management of primary immunodeficiency. Journal of Allergy and Clinical Immunology, 136(5), 1186-1205.e1178. https://doi.org/10.1016/j.jaci.2015.04.049  

Bousfiha, A., Moundir, A., Tangye, S. G., Picard, C., Jeddane, L., Al-Herz, W., Rundles, C. C., Franco, J. L., Holland, S. M., Klein, C., Morio, T., Oksenhendler, E., Puel, A., Puck, J., Seppänen, M. R. J., Somech, R., Su, H. C., Sullivan, K. E., Torgerson, T. R., & Meyts, I. (2022). The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. Journal of clinical immunology, 42(7), 1508-1520. https://doi.org/10.1007/s10875-022-01352-z  

Bousfiha, A. A., Jeddane, L., Moundir, A., Poli, M. C., Aksentijevich, I., Cunningham-Rundles, C., Hambleton, S., Klein, C., Morio, T., Picard, C., Puel, A., Rezaei, N., Seppänen, M. R. J., Somech, R., Su, H. C., Sullivan, K. E., Torgerson, T. R., Tangye, S. G., & Meyts, I. (2025). The 2024 update of IUIS phenotypic classification of human inborn errors of immunity. Journal of Human Immunity, 1(1), e20250002. https://doi.org/10.70962/jhi.20250002  

Bucciol, G., Delafontaine, S., Meyts, I., & Poli, C. (2024). Inborn errors of immunity: A field without frontiers. Immunological Reviews, 322(1), 15-27. https://doi.org/10.1111/imr.13297  

Buchbinder, D., Nugent, D. J., & Fillipovich, A. H. (2014). Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet, 7, 55-66. https://doi.org/10.2147/tacg.S58444  

Buckley, R. H. (2002). Primary cellular immunodeficiencies. J Allergy Clin Immunol, 109(5), 747-757. https://doi.org/10.1067/mai.2002.123617  

Cardenas-Morales, M., & Hernandez-Trujillo, V. P. (2022). Agammaglobulinemia: from X-linked to Autosomal Forms of Disease. Clin Rev Allergy Immunol, 63(1), 22-35. https://doi.org/10.1007/s12016-021-08870-5  

Casanova, J.-L., & Abel, L. (2007). Primary Immunodeficiencies: A Field in Its Infancy. Science, 317(5838), 617-619. https://doi.org/doi:10.1126/science.1142963  

Casanova, J.-L., & Abel, L. (2022). From rare disorders of immunity to common determinants of infection: Following the mechanistic thread. Cell, 185(17), 3086-3103. https://doi.org/10.1016/j.cell.2022.07.004  

Casanova, J.-L., & Anderson, M. S. (2023). Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs. The Journal of Clinical Investigation, 133(3). https://doi.org/10.1172/JCI166283   

Casanova, J.-L., Conley, M. E., Seligman, S. J., Abel, L., & Notarangelo, L. D. (2014). Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. Journal of Experimental Medicine, 211(11), 2137-2149. https://doi.org/10.1084/jem.20140520  

Castagnoli, R., Delmonte, O. M., Calzoni, E., & Notarangelo, L. D. (2019). Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives. Front Pediatr, 7, 295. https://doi.org/10.3389/fped.2019.00295  

Cavazzana-Calvo, M., Hacein-Bey, S., Basile, G. d. S., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.-L., Bousso, P., Deist, F. L., & Fischer, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288(5466), 669-672. https://doi.org/doi:10.1126/science.288.5466.669  

Chan, A., Scalchunes, C., Boyle, M., & Puck, J. M. (2011). Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey. Clin Immunol, 138(1), 3-8. https://doi.org/10.1016/j.clim.2010.09.010  

Chapel, H., Prevot, J., Gaspar, H. B., Español, T., Bonilla, F. A., Solis, L., & Drabwell, J. (2014). Primary Immune Deficiencies – Principles of Care [Hypothesis and Theory]. Frontiers in Immunology, Volume 5 - 2014. https://doi.org/10.3389/fimmu.2014.00627

Chen, R., Lukianova, E., van der Loeff, I. S., Spegarova, J. S., Willet, J. D. P., James, K. D., Ryder, E. J., Griffin, H., IJspeert, H., Gajbhiye, A., Lamoliatte, F., Marin-Rubio, J. L., Woodbine, L., Lemos, H., Swan, D. J., Pintar, V., Sayes, K., Ruiz-Morales, E. R., Eastham, S.,…Hambleton, S. (2024). NUDCD3 deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome. Science Immunology, 9(95), eade5705. https://doi.org/doi:10.1126/sciimmunol.ade5705  

Chinnici, A., Beneforti, L., Pegoraro, F., Trambusti, I., Tondo, A., Favre, C., Coniglio, M. L., & Sieni, E. (2023). Approaching hemophagocytic lymphohistiocytosis [Review]. Frontiers in Immunology, Volume 14 - 2023. https://doi.org/10.3389/fimmu.2023.1210041  

Chong-Neto, H. J., Radwan, N., Condino-Neto, A., Rosário Filho, N. A., Ortega-Martell, J. A., & El-Sayed, Z. A. (2024). Newborn screening for inborn errors of immunity: The status worldwide. World Allergy Organ J, 17(6), 100920. https://doi.org/10.1016/j.waojou.2024.100920  

Cinetto, F., Neri, R., Vianello, F., Visentin, A., Barilà, G., Gianese, S., Lanciarotta, A., Milito, C., Rattazzi, M., Piazza, F., Trentin, L., Zambello, R., Agostini, C., & Scarpa, R. (2021). Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies. PLoS One, 16(3), e0247717. https://doi.org/10.1371/journal.pone.0247717  

Cole, T., McLean‐Tooke, A., Loh, R., Quinn, P., Peake, J., Sinclair, J., & Smart, J. . (2018). P48: ASCIA TRANSPLANTATION AND PRIMARY IMMUNODEFICIENCY (TAPID) PROJECT. Internal Medicine Journal, 48(S6), 18-19. https://doi.org/10.1111/imj.48_14077  

Cole, T., Pearce, M. S., Cant, A. J., Cale, C. M., Goldblatt, D., & Gennery, A. R. (2013). Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. Journal of Allergy and Clinical Immunology, 132(5), 1150-1155. https://doi.org/10.1016/j.jaci.2013.05. ng the Lives of People With Primary Immunodeficiencies (PI) With Early Testing and Diagnosis. Front Immunol, 9, 1439. https://doi.org/10.3389/fimmu.2018.01439  

Cooper, M. A., Pommering, T. L., & Korányi, K. (2003). Primary immunodeficiencies. Am Fam Physician, 68(10), 2001-2008.

Coss, S. L., Zhou, D., Chua, G. T., Aziz, R. A., Hoffman, R. P., Wu, Y. L., Ardoin, S. P., Atkinson, J. P., & Yu, C.-Y. (2023). The complement system and human autoimmune diseases. Journal of Autoimmunity, 137, 102979. https://doi.org/10.1016/j.jaut.2022.102979  

Cunningham-Rundles, C. (2012). The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program, 2012, 301-305. https://doi.org/10.1182/asheducation-2012.1.301  

Dahl, C., Petersen, I., Ilkjær, F. V., Westh, L., Katzenstein, T. L., Hansen, A.-B. E., Nielsen, T. L., Larsen, C. S., Johansen, I. S., & Rasmussen, L. D. (2023). Missed Opportunities to Diagnose Common Variable Immunodeficiency: a Population-Based Case–Control Study Identifying Indicator Diseases for Common Variable Immunodeficiency. Journal of clinical immunology, 43(8), 2104-2114. https://doi.org/10.1007/s10875-023-01590-9  

De Decker, H. P., & Lawrenson, J. B. (2001). The 22q11.2 deletion: From diversity to a single gene theory. Genetics in Medicine, 3(1), 2-5. https://doi.org/10.1097/00125817-200101000-00002  

Dvorak, C. C., Haddad, E., Heimall, J., Dunn, E., Buckley, R. H., Kohn, D. B., Cowan, M. J., Pai, S. Y., Griffith, L. M., Cuvelier, G. D. E., Eissa, H., Shah, A. J., O'Reilly, R. J., Pulsipher, M. A., Wright, N. A. M., Abraham, R. S., Satter, L. F., Notarangelo, L. D., & Puck, J. M. (2023). The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 Definitions. J Allergy Clin Immunol, 151(2), 539-546. https://doi.org/10.1016/j.jaci.2022.10.022  

EBMT/ESID. (2017). EBMT/ESID Guidelines for haematopoietic stem cell transplantation (HSCT) for primary immunodeficiencies HSCT Guidelines. https://www.ebmt.org/ebmt/documents/esid-ebmt-hsct-guidelines-2017

Fernández-Cruz, E., Alecsandru, D., & Ramón, S. S. (2009). Mechanisms of action of immune globulin. Clinical and Experimental Immunology, 157(Supplement_1), 1-2. https://doi.org/10.1111/j.1365-2249.2009.03955.x  

Firatoglu, H., Aytekin, C., Dogu, F., Bal, S. K., Haskologlu, S., Boztug, K., & Ikinciogullari, A. (2025). Evaluation of Patients with Combined Immunodeficiency: A Single Center Experience. Iran J Immunol, 22(1), 89-99. https://doi.org/10.22034/iji.2025.103499.2844  

Fischer, A. (2000). Severe combined immunodeficiencies (SCID). Clin Exp Immunol, 122(2), 143-149. https://doi.org/10.1046/j.1365-2249.2000.01359.x  

Fischer, A., & Rausell, A. (2018). What do primary immunodeficiencies tell us about the essentiality/redundancy of immune responses? Seminars in Immunology, 36, 13-16. https://doi.org/10.1016/j.smim.2017.12.001   

Fomin, A. B., Pastorino, A. C., Kim, C. A., Pereira, C. A., Carneiro-Sampaio, M., & Abe-Jacob, C. M. (2010). DiGeorge Syndrome: a not so rare disease. Clinics (Sao Paulo), 65(9), 865-869. https://doi.org/10.1590/s1807-59322010000900009  

Fornes, O., Jia, A., Kuehn, H. S., Min, Q., Pannicke, U., Schleussner, N., Thouenon, R., Yu, Z., de los Angeles Astbury, M., Biggs, C. M., Galicchio, M., Garcia-Campos, J. A., Gismondi, S., Gonzalez Villarreal, G., Hildebrand, K. J., Hönig, M., Hou, J., Moshous, D., Pittaluga, S.,…Wang, J.-Y. (2023). A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency. Science Immunology, 8(79), eade7953. https://doi.org/doi:10.1126/sciimmunol.ade7953  

Frank, M. M. (2010). Complement disorders and hereditary angioedema. J Allergy Clin Immunol, 125(2 Suppl 2), S262-271. https://doi.org/10.1016/j.jaci.2009.10.063  

Gardulf, A. (2007). Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route. BioDrugs, 21(2), 105-116. https://doi.org/10.2165/00063030-200721020-00005   

Gaspar, J., Gerritsen, B., & Jones, A. (1998). Immunoglobulin replacement treatment by rapid subcutaneous infusion. Archives of Disease in Childhood, 79(1), 48. https://doi.org/10.1136/adc.79.1.48  

George, M. R. (2014). Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med, 5, 69-86. https://doi.org/10.2147/jbm.S46255  

Gray, P. E. A., Namasivayam, M., & Ziegler, J. B. (2012). Recurrent infection in children: When and how to investigate for primary immunodeficiency? Journal of Paediatrics and Child Health, 48(3), 202-209. https://doi.org/10.1111/j.1440-1754.2011.02080.x  

Grosserichter-Wagener, C., Franco-Gallego, A., Ahmadi, F., Moncada-Vélez, M., Dalm, V. A. S. H., Rojas, J. L., Orrego, J. C., Correa Vargas, N., Hammarström, L., Schreurs, M. W. J., Dik, W. A., van Hagen, P. M., Boon, L., van Dongen, J. J. M., van der Burg, M., Pan-Hammarström, Q., Franco, J. L., & van Zelm, M. C. (2020). Defective formation of IgA memory B cells, Th1 and Th17 cells in symptomatic patients with selective IgA deficiency. Clinical & Translational Immunology, 9(5), e1130. https://doi.org/10.1002/cti2.1130  

Gruber, C., & Bogunovic, D. (2020). Incomplete penetrance in primary immunodeficiency: a skeleton in the closet. Hum Genet, 139(6-7), 745-757. https://doi.org/10.1007/s00439-020-02131-9  

Guérin, A., Kerner, G., Marr, N., Markle, J. G., Fenollar, F., Wong, N., Boughorbel, S., Avery, D. T., Ma, C. S., Bougarn, S., Bouaziz, M., Béziat, V., Della Mina, E., Oleaga-Quintas, C., Lazarov, T., Worley, L., Nguyen, T., Patin, E., Deswarte, C.,…Casanova, J.-L. (2018). IRF4 haploinsufficiency in a family with Whipple’s disease. eLife, 7, e32340. https://doi.org/10.7554/eLife.32340  

Guo, Y., Tian, X., Wang, X., & Xiao, Z. (2018). Adverse Effects of Immunoglobulin Therapy. Front Immunol, 9, 1299. https://doi.org/10.3389/fimmu.2018.01299  

Heather, N., de Hora, M., Brothers, S., Grainger, P., Knoll, D., & Webster, D. (2022). Introducing Newborn Screening for Severe Combined Immunodeficiency-The New Zealand Experience. Int J Neonatal Screen, 8(2). https://doi.org/10.3390/ijns8020033   

Heimall, J., & Cowan, M. J. (2017). Long term outcomes of severe combined immunodeficiency: therapy implications. Expert Rev Clin Immunol, 13(11), 1029-1040. https://doi.org/10.1080/1744666x.2017.1381558  

Henter, J. I., Sieni, E., Eriksson, J., Bergsten, E., Hed Myrberg, I., Canna, S. W., Coniglio, M. L., Cron, R. Q., Kernan, K. F., Kumar, A. R., Lehmberg, K., Minoia, F., Naqvi, A., Ravelli, A., Tang, Y. M., Bottai, M., Bryceson, Y. T., Horne, A., & Jordan, M. B. (2024). Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited. Blood, 144(22), 2308-2318. https://doi.org/10.1182/blood.2024025077  

Holland, S. M. (2013). Chronic granulomatous disease. Hematol Oncol Clin North Am, 27(1), 89-99, viii. https://doi.org/10.1016/j.hoc.2012.11.002

Houghton, B. C., & Booth, C. (2021). Gene Therapy for Primary Immunodeficiency. Hemasphere, 5(1), e509. https://doi.org/10.1097/hs9.0000000000000509  

Inwald, D. P., Peters, M. J., Walshe, D., Jones, A., Davies, E. G., & Klein, N. J. (2000). Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome. Clin Exp Immunol, 120(3), 499-502. https://doi.org/10.1046/j.1365-2249.2000.01235.x  

Israel, L., Wang, Y., Bulek, K., Della Mina, E., Zhang, Z., Pedergnana, V., Chrabieh, M., Lemmens, N. A., Sancho-Shimizu, V., Descatoire, M., Lasseau, T., Israelsson, E., Lorenzo, L., Yun, L., Belkadi, A., Moran, A., Weisman, L. E., Vandenesch, F., Batteux, F.,…Puel, A. (2017). Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. Cell, 168(5), 789-800.e710. https://doi.org/10.1016/j.cell.2017.01.039  

Jin, Y., Mazza, C., Christie, J. R., Giliani, S., Fiorini, M., Mella, P., Gandellini, F., Stewart, D. M., Zhu, Q., Nelson, D. L., Notarangelo, L. D., & Ochs, H. D. (2004). Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood, 104(13), 4010-4019. https://doi.org/10.1182/blood-2003-05-1592  

Johnson, M. B., Ogishi, M., Domingo-Vila, C., De Franco, E., Wakeling, M. N., Imane, Z., Resnick, B., Williams, E., Galão, R. P., Caswell, R., Russ-Silsby, J., Seeleuthner, Y., Rinchai, D., Fagniez, I., Benson, B., Dufort, M. J., Speake, C., Smithmyer, M. E., Hudson, M.,…Oram, R. A. (2024). Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency. J Exp Med, 221(6). https://doi.org/10.1084/jem.20231704  

Jolles, S., Orange, J. S., Gardulf, A., Stein, M. R., Shapiro, R., Borte, M., & Berger, M. (2015). Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease. Clinical and Experimental Immunology, 179(2), 146-160. https://doi.org/10.1111/cei.12485  

Jolles, S., Sewell, W. A., & Misbah, S. A. (2005). Clinical uses of intravenous immunoglobulin. Clin Exp Immunol, 142(1), 1-11. https://doi.org/10.1111/j.1365-2249.2005.02834.x

Jolles, S., & Sleasman, J. W. (2011). Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach. Advances in Therapy, 28(7), 521-533. https://doi.org/10.1007/s12325-011-0036-y  

Justiz-Vaillant, A. A., Hoyte, T., Davis, N., Deonarinesingh, C., De Silva, A., Dhanpaul, D., Dookhoo, C., Doorpat, J., Dopson, A., Durgapersad, J., Palmer, C., Asin-Milan, O., Williams-Persad, A. F.-A., & Arozarena-Fundora, R. (2023). A Systematic Review of the Clinical Diagnosis of Transient Hypogammaglobulinemia of Infancy. Children, 10(8), 1358. https://www.mdpi.com/2227-9067/10/8/1358  

Kaçar, A. G., & Celkan, T. T. (2022). Hemophagocytic Lymphohistiocytosis. Balkan Med J, 39(5), 309-317. https://doi.org/10.4274/balkanmedj.galenos.2022.2022-4-83  

Kang, E. M., Marciano, B. E., DeRavin, S., Zarember, K. A., Holland, S. M., & Malech, H. L. (2011). Chronic granulomatous disease: Overview and hematopoietic stem cell transplantation. Journal of Allergy and Clinical Immunology, 127(6), 1319-1326. https://doi.org/10.1016/j.jaci.2011.03.028  

Karhan, A. N., Esenboğa, S., Gümüş, E., Karaatmaca, B., Cagdas, D., Demir, H., Saltik Temizel İ, N., Özen, H., Yüce, A., & Tezcan, İ. (2022). Nutritional status of children with primary immunodeficiency: A single center experience. Pediatr Int, 64(1), e14996. https://doi.org/10.1111/ped.14996  

Kavanagh, D., Barratt, J., Schubart, A., Webb, N. J. A., Meier, M., & Fakhouri, F. (2025). Factor B as a therapeutic target for the treatment of complement-mediated diseases. Front Immunol, 16, 1537974. https://doi.org/10.3389/fimmu.2025.1537974  

Kirkpatrick, P., & Riminton, S. (2007). Primary Immunodeficiency Diseases in Australia and New Zealand. Journal of clinical immunology, 27(5), 517-524. https://doi.org/10.1007/s10875-007-9105-z  

Kobrynski, L. (2012). Subcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseases. Biologics, 6, 277-287. https://doi.org/10.2147/btt.S25188  

Kohn, D. B., Hershfield, M. S., Puck, J. M., Aiuti, A., Blincoe, A., Gaspar, H. B., Notarangelo, L. D., & Grunebaum, E. (2019). Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. Journal of Allergy and Clinical Immunology, 143(3), 852-863. https://doi.org/10.1016/j.jaci.2018.08.024  

Kostel Bal, S., Giuliani, S., Block, J., Repiscak, P., Hafemeister, C., Shahin, T., Kasap, N., Ransmayr, B., Miao, Y., van de Wetering, C., Frohne, A., Jimenez Heredia, R., Schuster, M., Zoghi, S., Hertlein, V., Thian, M., Bykov, A., Babayeva, R., Bilgic Eltan, S.,…Boztug, K. (2023). Biallelic NFATC1 mutations cause an inborn error of immunity with impaired CD8+ T-cell function and perturbed glycolysis. Blood, 142(9), 827-845. https://doi.org/10.1182/blood.2022018303  

Kuo, C. Y., Garabedian, E., Puck, J., Cowan, M. J., Sullivan, K. E., Buckley, R. H., Cunningham-Rundles, C., Marsh, R., Candotti, F., & Kohn, D. B. (2020). Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry. J Clin Immunol, 40(8), 1124-1131. https://doi.org/10.1007/s10875-020-00857-9  

Larson, R. S., & Butler, M. G. (1995). Use of fluorescence in situ hybridization (FISH) in the diagnosis of DiGeorge sequence and related diseases. Diagn Mol Pathol, 4(4), 274-278. https://doi.org/10.1097/00019606-199512000-00008  

Lee, T. K., Gereige, J. D., & Maglione, P. J. (2021). State-of-the-art diagnostic evaluation of common variable immunodeficiency. Ann Allergy Asthma Immunol, 127(1), 19-27. https://doi.org/10.1016/j.anai.2021.03.005  

Lehmberg, K., Moshous, D., & Booth, C. (2019). Haematopoietic Stem Cell Transplantation for Primary Haemophagocytic Lymphohistiocytosis. Front Pediatr, 7, 435. https://doi.org/10.3389/fped.2019.00435  

Leiding, J. W., & Forbes, L. R. (2019). Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases. The Journal of Allergy and Clinical Immunology: In Practice, 7(3), 761-773. https://doi.org/10.1016/j.jaip.2018.12.017  

Li, Y., Yu, Z., Schenk, M., Lagovsky, I., Illig, D., Walz, C., Rohlfs, M., Conca, R., Muise, A. M., Snapper, S. B., Uhlig, H. H., Garty, B. Z., Klein, C., & Kotlarz, D. (2023). Human MD2 deficiency-an inborn error of immunity with pleiotropic features. J Allergy Clin Immunol, 151(3), 791-796.e797. https://doi.org/10.1016/j.jaci.2022.09.033  

Li, Z., & Mahmood, I. (2024). Immunoglobulin therapies for primary immunodeficiency diseases (part 2): considerations for dosing strategies. Immunotherapy, 16(13), 895-905. https://doi.org/10.1080/1750743x.2024.2382074   

Lingman-Framme, J., & Fasth, A. (2013). Subcutaneous Immunoglobulin for Primary and Secondary Immunodeficiencies: an Evidence-Based Review. Drugs, 73(12), 1307-1319. https://doi.org/10.1007/s40265-013-0094-3  

Loh, R. K., Vale, S., & McLean-Tooke, A. (2013). Quantitative serum immunoglobulin tests. Aust Fam Physician, 42(4), 195-198.

Lucas, C. L. (2024). Human genetic errors of immunity illuminate an adaptive arsenal model of rapid defenses. Trends in Immunology, 45(2), 113-126. https://doi.org/10.1016/j.it.2023.12.006  

Ma, C. S., & Tangye, S. G. (2019). Flow Cytometric-Based Analysis of Defects in Lymphocyte Differentiation and Function Due to Inborn Errors of Immunity [Review]. Frontiers in Immunology, Volume 10 - 2019. https://doi.org/10.3389/fimmu.2019.02108  

Mallick, R., Hahn, N., & Scalchunes, C. (2025). Immunoglobulin replacement therapy in patients with primary and secondary immunodeficiencies: impact of infusion method on immunoglobulin-specific perceptions of quality of life and treatment satisfaction. Allergy, Asthma & Clinical Immunology, 21(1), 2. https://doi.org/10.1186/s13223-024-00939-y  

Marsh, R. A., Vaughn, G., Kim, M.-O., Li, D., Jodele, S., Joshi, S., Mehta, P. A., Davies, S. M., Jordan, M. B., Bleesing, J. J., & Filipovich, A. H. (2010). Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood, 116(26), 5824-5831. https://doi.org/10.1182/blood-2010-04-282392  

Marshall, J. S., Warrington, R., Watson, W., & Kim, H. L. (2018). An introduction to immunology and immunopathology. Allergy, Asthma & Clinical Immunology, 14(2), 49. https://doi.org/10.1186/s13223-018-0278-1  

McCusker, C., Upton, J., & Warrington, R. (2018). Primary immunodeficiency. Allergy, Asthma & Clinical Immunology, 14(2), 61. https://doi.org/10.1186/s13223-018-0290-5  

McCusker, C., & Warrington, R. (2011). Primary immunodeficiency. Allergy, Asthma & Clinical Immunology, 7(1), S11. https://doi.org/10.1186/1710-1492-7-S1-S11  

McLean-Tooke, A., Spickett, G. P., & Gennery, A. R. (2007). Immunodeficiency and Autoimmunity in 22q11.2 Deletion Syndrome. Scandinavian Journal of Immunology, 66(1), 1-7. https://doi.org/https://doi.org/10.1111/j.1365-3083.2007.01949.x  

McMurray, J. C., Schornack, B. J., Weskamp, A. L., Park, K. J., Pollock, J. D., Day, W. G., Brockshus, A. T., Beakes, D. E., Schwartz, D. J., Mikita, C. P., & Pittman, L. M. (2024). Immunodeficiency: Complement disorders. Allergy Asthma Proc, 45(5), 305-309. https://doi.org/10.2500/aap.2024.45.240050  

Mickey, D., Camacho, J. V., Khan, A., & Kaufman, D. (2024). Immunodeficiency: Quantitative and qualitative phagocytic cell defects. Allergy Asthma Proc, 45(5), 299-304. https://doi.org/10.2500/aap.2024.45.240049  

Mitchell, R., Nivison-Smith, I., Anazodo, A., Tiedemann, K., Shaw, P., Teague, L., Fraser, C., Carter, T., Tapp, H., Alvaro, F., & O’Brien, T. A. (2013). Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Biology of Blood and Marrow Transplantation, 19(3), 338-343. https://doi.org/10.1016/j.bbmt.2012.11.619  

Mizoguchi, Y., & Okada, S. (2021). Inborn errors of STAT1 immunity. Current Opinion in Immunology, 72, 59-64. https://doi.org/10.1016/j.coi.2021.02.009  

Mustillo, P. J., Sullivan, K. E., Chinn, I. K., Notarangelo, L. D., Haddad, E., Davies, E. G., de la Morena, M. T., Hartog, N., Yu, J. E., Hernandez-Trujillo, V. P., Ip, W., Franco, J., Gambineri, E., Hickey, S. E., Varga, E., & Markert, M. L. (2023). Clinical Practice Guidelines for the Immunological Management of Chromosome 22q11.2 Deletion Syndrome and Other Defects in Thymic Development. J Clin Immunol, 43(2), 247-270. https://doi.org/10.1007/s10875-022-01418-y  

Neven, B., & Ferrua, F. (2020). Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT [Mini Review]. Frontiers in Pediatrics, Volume 7 - 2019. https://doi.org/10.3389/fped.2019.00552  

Nicolay, U., Haag, S., Eichmann, F., Herget, S., Spruck, D., & Gardulf, A. (2005). Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapy. Quality of Life Research, 14(7), 1683-1691. https://doi.org/10.1007/s11136-005-1746-x  

Notarangelo, L. D., Bacchetta, R., Casanova, J.-L., & Su, H. C. (2020). Human inborn errors of immunity: An expanding universe. Science Immunology, 5(49), eabb1662. https://doi.org/10.1126/sciimmunol.abb1662  

Ochs, H. D., Smith, C. E., & Puck, J. M. (2013). Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. Oxford University Press. https://doi.org/10.1093/med/9780195389838.001.0001   

Ochs, H. D., Gupta, S., Kiessling, P., Nicolay, U., & Berger, M. (2006). Safety and Efficacy of Self-Administered Subcutaneous Immunoglobulin in Patients with Primary Immunodeficiency Diseases. Journal of clinical immunology, 26(3), 265-273. https://doi.org/10.1007/s10875-006-9021-7   

Oikonomopoulou, Z., Shulman, S., Mets, M., & Katz, B. (2022). Chronic Granulomatous Disease: an Updated Experience, with Emphasis on Newly Recognized Features. J Clin Immunol, 42(7), 1411-1419. https://doi.org/10.1007/s10875-022-01294-6  

O'Keefe, A. W., Halbrich, M., Ben-Shoshan, M., & McCusker, C. (2016). Primary immunodeficiency for the primary care provider. Paediatrics & Child Health, 21(2), e10-e14. https://doi.org/10.1093/pch/21.2.e10  

Oliveira, J. B., & Fleisher, T. A. (2010). Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol, 125(2 Suppl 2), S297-305. https://doi.org/10.1016/j.jaci.2009.08.043  

Ozdemir, O. (2021). Primary immunodeficiency diseases in the newborn. North Clin Istanb, 8(4), 405-413. https://doi.org/10.14744/nci.2020.43420  

Palmeira, P., Quinello, C., Silveira-Lessa, A. L., Zago, C. A., & Carneiro-Sampaio, M. (2012). IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol, 2012, 985646. https://doi.org/10.1155/2012/985646  

Panch, S. R., Szymanski, J., Savani, B. N., & Stroncek, D. F. (2017). Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy. Biology of Blood and Marrow Transplantation, 23(8), 1241-1249. https://doi.org/10.1016/j.bbmt.2017.05.003  

Perez, E., Bonilla, F. A., Orange, J. S., & Ballow, M. (2017). Specific Antibody Deficiency: Controversies in Diagnosis and Management. Front Immunol, 8, 586. https://doi.org/10.3389/fimmu.2017.00586  

Picard, C., Bobby Gaspar, H., Al-Herz, W., Bousfiha, A., Casanova, J.-L., Chatila, T., Crow, Y. J., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Holland, S. M., Klein, C., Morio, T., Ochs, H. D., Oksenhendler, E., Puck, J., Tang, M. L. K., Tangye, S. G., Torgerson, T. R., & Sullivan, K. E. (2018). International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity. Journal of clinical immunology, 38(1), 96-128. https://doi.org/10.1007/s10875-017-0464-9  

Picard, C., & Fischer, A. (2014). Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. European Journal of Immunology, 44(10), 2854-2861. https://doi.org/10.1002/eji.201444669  

Poli, M. C., Aksentijevich, I., Bousfiha, A. A., Cunningham-Rundles, C., Hambleton, S., Klein, C., Morio, T., Picard, C., Puel, A., Rezaei, N., Seppänen, M. R. J., Somech, R., Su, H. C., Sullivan, K. E., Torgerson, T. R., Meyts, I., & Tangye, S. G. (2025). Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. Journal of Human Immunity, 1(1), e20250003. https://doi.org/10.70962/jhi.20250003  

Radinsky, S., & Bonagura, V. R. (2003). Subcutaneous immunoglobulin infusion as an alternative to intravenous immunoglobulin. Journal of Allergy and Clinical Immunology, 112(3), 630-633. https://doi.org/10.1016/S0091-6749(03)01781-0

Rae, W., Sowerby, J. M., Verhoeven, D., Youssef, M., Kotagiri, P., Savinykh, N., Coomber, E. L., Boneparth, A., Chan, A., Gong, C., Jansen, M. H., du Long, R., Santilli, G., Simeoni, I., Stephens, J., Wu, K., Zinicola, M., Allen, H. L., Baxendale, H.,…Smith, K. G. C. (2022). Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations. Science Immunology, 7(74), eabn3800. https://doi.org/doi:10.1126/sciimmunol.abn3800  

Raje, N., & Dinakar, C. (2015). Overview of Immunodeficiency Disorders. Immunol Allergy Clin North Am, 35(4), 599-623. https://doi.org/10.1016/j.iac.2015.07.001  

Refaat, M., Oujane, C., Kholaiq, H., Aadam, Z., Errami, A., Baghad, B., Boussetta, S., El Kettani, A., Benhsaien, I., Ailal, F., Bourhanbour, A. D., El Bakkouri, J., & Bousfiha, A. A. (2024). Innate immunodeficiencies: a group of primary immunodeficiencies predisposing exclusively to common diseases. Egyptian Journal of Medical Human Genetics, 25(1), 134. https://doi.org/10.1186/s43042-024-00604-4  

Richards, S., Gennery, A. R., Davies, E. G., Wong, M., Shaw, P. J., Peake, J., Fraser, C., Gray, P., Brothers, S., Sinclair, J., Prestidge, T., Preece, K., Quinn, P., Ramachandran, S., Loh, R., McLean-Tooke, A., Mitchell, R., & Cole, T. (2020). Diagnosis and management of severe combined immunodeficiency in Australia and New Zealand. J Paediatr Child Health, 56(10), 1508-1513. https://doi.org/10.1111/jpc.15158  

Rider, N. L., Truxton, A., Ohrt, T., Margolin-Katz, I., Horan, M., Shin, H., Davila, R., Tenembaum, V., Quinn, J., Modell, V., Modell, F., Orange, J. S., Branner, A., & Senerchia, C. (2024). Validating inborn error of immunity prevalence and risk with nationally representative electronic health record data. Journal of Allergy and Clinical Immunology, 153(6), 1704-1710. https://doi.org/10.1016/j.jaci.2024.01.011  

Riminton, D. S., Hartung, H.-P., & Reddel, S. W. (2011). Managing the risks of immunosuppression. Current Opinion in Neurology, 24(3). https://doi.org/10.1097/WCO.0b013e328346d47d  

Roos, D. (2016). Chronic granulomatous disease. Br Med Bull, 118(1), 50-63. https://doi.org/10.1093/bmb/ldw009  

Rosen, F. S., Wedgwood, R. J., Aiuti, F., Cooper, M. D., Good, R. A., Hanson, L. A., Hitzig, W. H., Matsumoto, S., Seligmann, M., Soothill, J. F., & Waldmann, T. A. (1983). Primary immunodeficiency diseases: Report prepared for the WHO by a scientific group on immunodeficiency. Clinical Immunology and Immunopathology, 28(3), 450-475. https://doi.org/10.1016/0090-1229(83)90112-5  

Salzer, U., Warnatz, K., & Peter, H. H. (2012). Common variable immunodeficiency: an update. Arthritis Res Ther, 14(5), 223. https://doi.org/10.1186/ar4032  

Seger, R. A. (2010). Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease. Immunology and Allergy Clinics of North America, 30(2), 195-208. https://doi.org/10.1016/j.iac.2010.01.003  

Segundo, G. R. S., & Condino-Neto, A. (2021). Treatment of patients with immunodeficiency: Medication, gene therapy, and transplantation. J Pediatr (Rio J), 97 Suppl 1(Suppl 1), S17-s23. https://doi.org/10.1016/j.jped.2020.10.005  

Shearer, W. T., Fleisher, T. A., Buckley, R. H., Ballas, Z., Ballow, M., Blaese, R. M., Bonilla, F. A., Conley, M. E., Cunningham-Rundles, C., Filipovich, A. H., Fuleihan, R., Gelfand, E. W., Hernandez-Trujillo, V., Holland, S. M., Hong, R., Lederman, H. M., Malech, H. L., Miles, S., Notarangelo, L. D.,…Winkelstein, J. (2014). Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol, 133(4), 961-966. https://doi.org/10.1016/j.jaci.2013.11.043  

Sjöholm, A. G., Jönsson, G., Braconier, J. H., Sturfelt, G., & Truedsson, L. (2006). Complement deficiency and disease: an update. Mol Immunol, 43(1-2), 78-85. https://doi.org/10.1016/j.molimm.2005.06.025  

Slade, C. A., Bosco, J. J., Binh Giang, T., Kruse, E., Stirling, R. G., Cameron, P. U., Hore-Lacy, F., Sutherland, M. F., Barnes, S. L., Holdsworth, S., Ojaimi, S., Unglik, G. A., De Luca, J., Patel, M., McComish, J., Spriggs, K., Tran, Y., Auyeung, P., Nicholls, K.,…van Zelm, M. C. (2018). Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults. Front Immunol, 9, 694. https://doi.org/10.3389/fimmu.2018.00694  

Sobh, A., & Bonilla, F. A. (2016). Vaccination in Primary Immunodeficiency Disorders. J Allergy Clin Immunol Pract, 4(6), 1066-1075. https://doi.org/10.1016/j.jaip.2016.09.012  

Soncini, E., Slatter, M. A., Jones, L. B. K. R., Hughes, S., Hodges, S., Flood, T. J., Barge, D., Spickett, G. P., Jackson, G. H., Collin, M. P., Abinun, M., Cant, A. J., & Gennery, A. R. (2009). Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. British Journal of Haematology, 145(1), 73-83. https://doi.org/10.1111/j.1365-2141.2009.07614.x  

Sriaroon, P., & Ballow, M. (2015). Immunoglobulin Replacement Therapy for Primary Immunodeficiency. Immunol Allergy Clin North Am, 35(4), 713-730. https://doi.org/10.1016/j.iac.2015.07.006   

Staudacher, O., & von Bernuth, H. (2024). Clinical presentation, diagnosis, and treatment of chronic granulomatous disease [Review]. Frontiers in Pediatrics, Volume 12 - 2024. https://doi.org/10.3389/fped.2024.1384550  

Stewart, O. J., Gruber, C., Randolph, H. E., Patel, R., Ramba, M., Calzoni, E., Huang, L. H., Levy, J., Buta, S., Lee, A., Sazeides, C., Prue, Z., Hoytema van Konijnenburg, D. P., Chinn, I. K., Pedroza, L. A., Lupski, J. R., Schmitt, E. G., Cooper, M. A., Puel, A.,…Bogunovic, D. (2025). Monoallelic expression can govern penetrance of inborn errors of immunity. Nature, 637(8048), 1186-1197. https://doi.org/10.1038/s41586-024-08346-4   

Stiehm, E. R., Casillas, A. M., Finkelstein, J. Z., Gallagher, K. T., Groncy, P. M., Kobayashi, R. H., Oleske, J. M., Roberts, R. L., Sandberg, E. T., & Wakim, M. E. (1998). Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: Use of an old method with a new product. Journal of Allergy and Clinical Immunology, 101(6), 848-849. https://doi.org/10.1016/S0091-6749(98)70314-8  

Sudhakar, M., Rikhi, R., Loganathan, S. K., Suri, D., & Singh, S. (2021). Autoimmunity in Wiskott-Aldrich Syndrome: Updated Perspectives. Appl Clin Genet, 14, 363-388. https://doi.org/10.2147/tacg.S213920  

Sullivan, K. E. (2022). The yin and the yang of early classical pathway complement disorders. Clin Exp Immunol, 209(2), 151-160. https://doi.org/10.1093/cei/uxac056  

Swain, S., Selmi, C., Gershwin, M. E., & Teuber, S. S. (2019). The clinical implications of selective IgA deficiency. J Transl Autoimmun, 2, 100025. https://doi.org/10.1016/j.jtauto.2019.100025  

Takahashi, K., Ip, W. E., Michelow, I. C., & Ezekowitz, R. A. (2006). The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol, 18(1), 16-23. https://doi.org/10.1016/j.coi.2005.11.014  

Tam, J. S., & Routes, J. M. (2013). Common variable immunodeficiency. Am J Rhinol Allergy, 27(4), 260-265. https://doi.org/10.2500/ajra.2013.27.3899  

Tangye, S. G., Al-Herz, W., Bousfiha, A., Chatila, T., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Holland, S. M., Klein, C., Morio, T., Ochs, H. D., Oksenhendler, E., Picard, C., Puck, J., Torgerson, T. R., Casanova, J.-L., & Sullivan, K. E. (2020). Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. Journal of clinical immunology, 40(1), 24-64. https://doi.org/10.1007/s10875-019-00737-x  

Tangye, S. G., Nguyen, T., Deenick, E. K., Bryant, V. L., & Ma, C. S. (2023). Inborn errors of human B cell development, differentiation, and function. Journal of Experimental Medicine, 220(7), e20221105. https://doi.org/10.1084/jem.20221105  

Thakar, M. S., Logan, B. R., Puck, J. M., Dunn, E. A., Buckley, R. H., Cowan, M. J., O'Reilly, R. J., Kapoor, N., Satter, L. F., Pai, S.-Y., Heimall, J., Chandra, S., Ebens, C. L., Chellapandian, D., Williams, O., Burroughs, L. M., Saldana, B. D., Rayes, A., Madden, L. M.,…Notarangelo, L. D. (2023). Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium. The Lancet, 402(10396), 129-140. https://doi.org/10.1016/S0140-6736(23)00731-6  

Thong, B. Y., Pawankar, R., Park, H. S., & Abdul Latiff, A. H. (2023). Evaluating immune responses to pneumococcal vaccines. Asia Pac Allergy, 13(3), 127-131. https://doi.org/10.5415/apallergy.0000000000000114  

Thouenon, R., Chentout, L., Moreno-Corona, N., Poggi, L., Lombardi, E. P., Hoareau, B., Schmitt, Y., Lagresle-Peyrou, C., Bustamante, J., André, I., Cavazzana, M., Durandy, A., Casanova, J.-L., Galicier, L., Fadlallah, J., Fischer, A., & Kracker, S. (2023). A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency. Journal of Experimental Medicine, 220(6), e20221292. https://doi.org/10.1084/jem.20221292  

Tiri, A., Masetti, R., Conti, F., Tignanelli, A., Turrini, E., Bertolini, P., Esposito, S., & Pession, A. (2021). Inborn Errors of Immunity and Cancer. Biology, 10(4), 313. https://doi.org/10.3390/biology10040313  

Toskov, V., Kaiser-Labusch, P., Lee-Kirsch, M. A., Wolf, C., Speckmann, C., Ehl, S., Wegehaupt, O., & group, P. s. (2024). Variable Syndromic Immunodeficiency in Patients with Biallelic PRIM1 Mutations. Journal of clinical immunology, 44(6), 129. https://doi.org/10.1007/s10875-024-01733-6  

Truedsson, L. (2015). Classical pathway deficiencies - A short analytical review. Mol Immunol, 68(1), 14-19. https://doi.org/10.1016/j.molimm.2015.05.007  

Tuovinen, E. A., Grönholm, J., Öhman, T., Pöysti, S., Toivonen, R., Kreutzman, A., Heiskanen, K., Trotta, L., Toiviainen-Salo, S., Routes, J. M., Verbsky, J., Mustjoki, S., Saarela, J., Kere, J., Varjosalo, M., Hänninen, A., & Seppänen, M. R. J. (2020). Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency. Journal of clinical immunology, 40(3), 503-514. https://doi.org/10.1007/s10875-020-00745-2  

Uzel, G., Orange, J. S., Poliak, N., Marciano, B. E., Heller, T., & Holland, S. M. (2010). Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. Clinical Infectious Diseases, 51(12), 1429-1434. https://doi.org/10.1086/657308  

Valiathan, R., Ashman, M., & Asthana, D. (2016). Effects of Ageing on the Immune System: Infants to Elderly. Scand J Immunol, 83(4), 255-266. https://doi.org/10.1111/sji.12413   

van der Made, C. I., Kersten, S., Chorin, O., Engelhardt, K. R., Ramakrishnan, G., Griffin, H., Schim van der Loeff, I., Venselaar, H., Rothschild, A. R., Segev, M., Schuurs-Hoeijmakers, J. H. M., Mantere, T., Essers, R., Esteki, M. Z., Avital, A. L., Loo, P. S., Simons, A., Pfundt, R., Warris, A.,…Hoischen, A. (2024). Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome. The American Journal of Human Genetics, 111(4), 791-804. https://doi.org/10.1016/j.ajhg.2024.02.013  

Vosughimotlagh, A., Rasouli, S. E., Rafiemanesh, H., Safarirad, M., Sharifinejad, N., Madanipour, A., Dos Santos Vilela, M. M., Heropolitańska-Pliszka, E., & Azizi, G. (2023). Clinical manifestation for immunoglobulin A deficiency: a systematic review and meta-analysis. Allergy, Asthma & Clinical Immunology, 19(1), 75. https://doi.org/10.1186/s13223-023-00826-y  

Wadbudhe, A. M., Meshram, R. J., & Tidke, S. C. (2023). Severe Combined Immunodeficiency (SCID) and Its New Treatment Modalities. Cureus, 15(10), e47759. https://doi.org/10.7759/cureus.47759  

Wu, Y., Sun, X., Kang, K., Yang, Y., Li, H., Zhao, A., & Niu, T. (2024). Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms. Journal of Hematology & Oncology, 17(1), 106. https://doi.org/10.1186/s13045-024-01621-x  

Xie, C. B., Jane-Wit, D., & Pober, J. S. (2020). Complement Membrane Attack Complex: New Roles, Mechanisms of Action, and Therapeutic Targets. Am J Pathol, 190(6), 1138-1150. https://doi.org/10.1016/j.ajpath.2020.02.006  

Yalcin Gungoren, E., Yorgun Altunbas, M., Dikici, U., Meric, Z., Eser Simsek, I., Kiykim, A., Can, S., Karabiber, E., Yakici, N., Orhan, F., Cokugras, H., Aydogan, M., Ozdemir, O., Bilgic Eltan, S., Baris, S., Ozen, A., & Karakoc-Aydiner, E. (2024). Insights into Patient Experiences with Facilitated Subcutaneous Immunoglobulin Therapy in Primary Immune Deficiency: A Prospective Observational Cohort. J Clin Immunol, 44(8), 169. https://doi.org/10.1007/s10875-024-01771-0  

Yazdani, R., Azizi, G., Abolhassani, H., & Aghamohammadi, A. (2017). Selective IgA Deficiency: Epidemiology, Pathogenesis, Clinical Phenotype, Diagnosis, Prognosis and Management. Scandinavian Journal of Immunology, 85(1), 3-12. https://doi.org/https://doi.org/10.1111/sji.12499  

Yazdani, R., Fekrvand, S., Shahkarami, S., Azizi, G., Moazzami, B., Abolhassani, H., & Aghamohammadi, A. (2019). The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol, 198, 19-30. https://doi.org/10.1016/j.clim.2018.11.007  

Yel, L. (2010). Selective IgA deficiency. J Clin Immunol, 30(1), 10-16. https://doi.org/10.1007/s10875-009-9357-x  

Younger, M. E. M., Aro, L., Blouin, W., Duff, C., Epland, K. B., Murphy, E., Sedlak, D., & Nurse Advisory Committee Immune Deficiency, F. (2013). Nursing Guidelines for Administration of Immunoglobulin Replacement Therapy. Journal of Infusion Nursing, 36(1). https://doi.org/10.1097/NAN.0b013e3182798af8  

Younger, M. E. M. e., IDF (2016). Guide for Nurses. Immunoglobulin Therapy for Primary Immunodeficiency Diseases. Immune Deficiency Foundation. https://primaryimmune.org/resources/print-material/idf-guide-for-nurses-immunoglobulin-therapy-for-primary-immunodeficiency-diseases

Yu, J. E., Azar, A. E., Chong, H. J., Jongco, A. M., 3rd, & Prince, B. T. (2018). Considerations in the Diagnosis of Chronic Granulomatous Disease. J Pediatric Infect Dis Soc, 7(suppl_1), S6-s11. https://doi.org/10.1093/jpids/piy007  

Zimmerman, C., & Shenoy, S. (2020). Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders—A Perspective [Perspective]. Frontiers in Immunology, Volume 11 - 2020. https://doi.org/10.3389/fimmu.2020.01791

NOTE: There is a separate ASCIA reference list for Hereditary Angioedema (HAE) publications on the ASCIA website www.allergy.org.au/hp/papers#p4

Content updated May 2025